Central Asian Journal of Medicine


The article is elucidates the theoretical aspects of the effective method development for the removal of protein-bound uremic toxins. It is shown that the methods of flow and differential scanning microcalorimetry are effective for the evaluation of the degree of ligand loading of human serum albumin with protein-bound uremic toxins. Acknowledgment - This work supported by INTAS-04-082-7065 grant program.

First Page


Last Page



1. Bajenov L.G., Kasimov Sh.Z., Kosnikova L.V., Pizayeva E.V., Gutnikova A.R. Biotechnological modification of sorption materials by microorganisms and their biologically active substances // NATO advanced study institute. – 2009. – Biodefence: advanced materials and methods for health protection. – P.57. 2. Kasimov Sh.Z., Mirishova S.A., Aripova D.S., Eshmuminov D.K. Haemosorption in complex management of gepatargy // NATO advanced study institute. – 2009. – Biodefence: advanced materials and methods for health protection. – P.42. 3. Agalou S., Ahmed N., Thomalley P.J., Dawnay A. Advanced glycation end product free adducts are cleared by dialysis // Ann NY Acad Sci. -2005. - Vol. 1043. - P.734-739. 4. Boure T., Vanholder R. Biochemical and clinical evidence for uremic toxicity // Artif Organs. – 2004. - Vol. 28. - P.248-253. 5. Bowmer C.J., Lindup W.E. Decreased drug binding in uraemia: effect of indoxylsulphate and other endogenous substances on the binding of drugs and dyes to humanalbumin // Biochem Pharmacol. - 1982. - Vol. 31. -P.319-323. 6. Chen R.F. Removal of fatty acids from serum albumin by charcoal treatment // J Biol Chem. -1967. - Vol. 242. - P.173-181. 7. Coassolo P., Sarrazin M., Sari J.C., Briand C. Microcalorimetric studies on the binding of some benzodiazepine derivatives to human serum albumin // Biochem Pharmacol. -1978. - Vol. 27. - P.2787- 2792. 8. Daugirdas J.T., Schneditz D. Protein bound toxins in uremia // ASAIOJ -1995. - 4 ЕМ. - P.719-724. 9. Henderson S.J., Lindup W.E. Renal organic acid transport: uptake by rat kidney slices of a furan dicarboxylic acid which inhibits plasma protein binding of acidic ligands in uremia // J Pharmacol Exp Ther. – 1992. - Vol. 263. -P.54-60. 10. Ikeda К., Yoshitomi H„ Nakayama T., Goto S., Kimura T. Plasma protein binding of frusemide in renal failure rabbits: investigation of endogenous protein binding inhibitors // J Pharm Pharmacol. – 1984. - Vol. 36. P.663-667. 11. Ivanov A.I., Sarnatskaya V.V., Maslenny V.N. Comparative study of albumin termodynamic parameters in ESRD patients treated by HD and CAPD // Abstracts of 3rd Intern. // Symp. On Uremic Toxicity, Nagoya, Japan. - 1997. - P.175. 12. Kawashima Y. Study on the uremic protein binding inhibitors as uremic toxin: toxic effect on erythroid colony formation, lymphocyte blast formation and renal function // Nippon Jinzo Gakkai Shi. – 1989. - Vol. 31. -P.1151-1161. 13. Lim C.F., Bernard B.F., de Jong M., Docter R., Krenning E.P., Hennemann G. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia // J Clin Endocrinol Metab. – 1993. - Vol. 76. - P.318-324. 14. Mc Namara P.J., Lalka D., Gibaldi M. Endogenous accumulation products and serum protein binding in uremia // J Lab Clin Med. - 1981. - Vol. 98. - P.730-740. 15. Nascimento M.M., Pasqual D.D., dos Santos J.E., Riella M.C. Six years of treatment with the HELP system of a patient with familial hypercholesterolemia. // Braz J MedBiol Res. – 2002. - Vol. 35. - P.775-782. 16. Nikolaev V.G., Samatskaya V.V, Bardakhyvskaya K.I., Susak Ya.M., Snejkova E.A., Chemomyz V.D., Tsymbalyuk R.S., Uvarov V.Yu., Gurina N.M. Efferent Therapy. - 2003. - Vol. 9. - P.26-39. 17. Niwa T., Ise M., Miyazaki T. Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate // Am J Nephrol. – 1994. - Vol. 14. - P.207- 212. 18. Niwa T., Yazawa T., Kodama T., Uehara Y., Maeda K., Yamada, K. Efficient removal of albumin-bound furancarboxylic acid, an inhibitor of erythropoiesis, by continuous ambulatory peritoneal dialysis // Nephron. -1990. -Vol. 56. - P.241-245. 19. Port F.K. Morbidity and mortality in dialysis patients // Kidney Int. – 1994. - Vol. 6. - P.1728-1737. 20. Sakai T., Takadate A., Otagiri M. Characterization of binding site of uremic toxins on human serum albumin // Biol Pharm Bull. - 1995. - Vol. 18. -P.1755-1761. 21. Sarnatskaya V.V., Ivanov A.I., Nikolaev V.G., Rotellar E., von Appen K., Haspar M., Maslenny V.N., Klinkmann H. Sructure and binding properties of semm albumin in uremic patients at different periods of hemodialysis // Artif Organs. - 1998. - Vol. 22. - P.107-115. 22. Sarnatskaya V.V., Lindup W.E., Niwa T., Ivanov A.I., Yushko L.A., Tjia J., Maslenny V.N., Korneeva L.N., Nikolaev V.G. Effect of protein-bound uraemic toxins on the thermodynamic characteristics of human albumin // Biochem Pharmacol. - 2002. - Vol. 63. - P.1287-1296. 23. Sarnatskaya V.V., Lindup W.E., Walther P., Maslenny V.N., Yushko L.A., Sidorenko A.S., Nikolaev A.V., Nikolaev V.G. Albumin, bilirubin, and activated carbon: new edges of an old triangle. Art if Cells Blood // Substit Immobil Biotechnol Journal. – 2002. - Vol. 30. - P.113-126. 24. Sudlow G., Birkett D.J., Wade D.N. Further characterization of specific drug binding sites on human serum albumin // Molecular Pharmacology. – 1976. - Vol. 12. - P.1052-1061. 25. Takamura N., Maruyama T., Otagiri M. Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia // Clinical Chemistry. -1997. - Vol. 43. - P.2274-2280. 26. Tsutsumi Y., Deguchi T., Takano M., Takadate A., Lindup W.E., Otagiri M. Renal disposition of a furan dicarboxylic acid and other uremic toxins in the rat // J. Pharmacology. - 2002. - Vol. 303. - P.880-887 27. Vanholder R., Glorieux G., Lameire N. New insights in uremic toxicity // Contrib Nephrol. – 2005. - Vol. 149. - P.315-324. 28. Vanholder R., De Smet R., Glorieux G., Argiles A., Baurmeister U., Brunet P., Clark W., Cohen G., De Deyn P.P., Deppisch R., Descamps-Latscha B., Henle T., Jorres A., Lemke H.D., Massy Z.A., Passlick-Deetjen J., Rodriguez M., Stegmayr B., Stenvinkel P., Tetta C., Wanner С., Zidek W. European Uremic Toxin Work Group (EUTox) // Review on uremic toxins: classification, concentration, and nterindividual variability // Kidney Int. - 2003. - Vol. 63. -P.1934-1943. 29. Vasileva R., Jakab M., Hasko F. Application of ion-exchange chromatography for the production of human albumin // J. Chromatography. -1981. - Vol. 30. - P.279-284. 30. Ward, R.A. Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application // Journal of the American Society of Nephrology. - 2005. - Vol. l16. - P.2421-2430. 31. Yang X.B., Hou F.F., Wu Q., Zhou H., Liu Z.R., Yang Y., Zhang X. Increased levels of advanced oxidation protein products are associated with atherosclerosis in chronic kidney disease // Zhonghua Nei Ke Za Zhi. - 2005. - Vol. 44. - P.342-346. 32. Certificate on the State registration, number 2647/2004 on 26.03.2004



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.